Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Starting treatment news

Show

From To
Life expectancy now near-normal in people with CD4 counts over 350 a year after starting therapy

A large study of 88,504 people with HIV on antiretroviral therapy (ART), published in The Lancet HIV journal and reported widely in the news, has found substantial

Published
15 May 2017
By
Gus Cairns
Protease inhibitor drug suppresses HIV in semen more slowly than drugs from other classes

Protease inhibitors may not be the best class of drug for people newly diagnosed with HIV to start treatment with, if they wish to quickly

Published
12 May 2017
By
Gus Cairns
Gay New Zealand welcomes removal of HIV meds restriction

The decision of New Zealand's drug regulator Pharmac to remove a restriction on when people newly-diagnosed with HIV can be put on medications will "significantly benefit people newly diagnosed with HIV and those living with HIV as well as efforts to prevent HIV transmission” according to the NZ AIDS Foundation. “New Zealand is one of few countries in the developed world to still have a restriction on treatment access,” the NZAF's Executive Director Jason Myers says. “Early treatment is a fundamental pillar of NZAFs Ending HIV programme."

Published
08 May 2017
From
Gay New Zealand
Fear of stigma is prompting young South Africans to seek early HIV treatment

Young South Africans are strongly motivated to seek HIV testing and treatment by a desire to maintain a healthy physical appearance and to appear normal

Published
04 May 2017
By
Keith Alcorn
Early ART highly acceptable and achieves excellent rates of viral suppression among young South African women

Early antiretroviral therapy (ART) is highly acceptable to the majority of young women with HIV in South Africa, according to research published in AIDS and Behavior.

Published
27 April 2017
By
Michael Carter
Health system navigators didn't improve ART initiation or TB treatment completion rates among people newly diagnosed with HIV in Durban

An intervention using health system navigators, phone support and text message reminders did not improve rates of people living with HIV initiating antiretroviral therapy (ART) or completing treatment

Published
10 April 2017
By
Michael Carter
Should Antiretroviral Therapy be Offered the Same Day as Diagnosis?

Andy Seale summarizes a discussion that took place on ITPC’s listserv about when to initiate antiretroviral therapy. The discussion included consideration of WHO’s recommendation for Same Day Start.

Published
23 March 2017
From
ITPC
Integrase inhibitors may increase risk of IRIS in late presenters for HIV treatment

HIV integrase inhibitors such as dolutegravir and raltegravir may increase the risk of immune reconstitution inflammatory syndrome (IRIS), studies from the Netherlands and France presented

Published
01 March 2017
By
Keith Alcorn
Across western Europe, migrants from all parts of the world start HIV treatment later

An analysis of over 150,000 people living with HIV in eleven western European countries shows that people born abroad are more likely to start HIV treatment with

Published
13 February 2017
By
Roger Pebody
Starting treatment quickly after diagnosis is not harmful for adolescents, Zimbabwe study finds

A lack of lengthy preparation before starting HIV treatment does not result in an increased risk of death or loss to follow-up in adolescents, a

Published
25 January 2017
By
Keith Alcorn
← First12345...75Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.